Medtronic, Inc. (MDT), Boston Scientific Corporation (BSX): Is This the Market’s Last Remaining Bargain?

Page 1 of 2

It is hard to remember a time when the market was as overheated as it is today; even during the tech bubble, there were non-tech stocks that were cheap. Today, few stocks in any sector are even worth a closer look based on earnings multiples.

Medtronic, Inc. (NYSE:MDT)However, one company — Medtronic, Inc. (NYSE:MDT) — may be the last remaining bargain in this bull market. Medtronic, Inc. (NYSE:MDT) sells at a steep discount to its peers due to a high degree of uncertainty regarding its future cash flows. But a closer look at the company’s diversified product portfolio and future opportunities makes the stock look attractive at current levels.

Strong business performance

As the market leader in many of the product markets it serves, Medtronic, Inc. (NYSE:MDT) enjoys the trust of doctors and scale of operations that few other companies can claim.

Although many of its products are not meaningfully differentiated from those of, say, Boston Scientific Corporation (NYSE:BSX), Medtronic, Inc. (NYSE:MDT) profits from high customer switching costs due to doctors’ reluctance to switch to a different brand if the one they are using suits their needs. Along with scale advantages that allow the company to match competitors’ prices, high switching costs allow Medtronic, Inc. (NYSE:MDT) to defend its leading market share.

Both Medtronic, Inc. (NYSE:MDT) and Boston Scientific Corporation (NYSE:BSX) suffered painful product recalls during the last few years, but Medtronic’s diverse product base allowed it to absorb the shock better than its competitor; Boston Scientific Corporation (NYSE:BSX) lost significant ground in the defibrillator market and is unlikely to recapture its market share.

Meanwhile, Boston Scientific Corporation (NYSE:BSX)’s bare metal stents have come under greater scrutiny after multiple independent studies have shown them to be no more effective than an aspirin regiment. As a result of these mishaps, the company lost more than $3 per share over the last four quarters.

Another of Medtronic’s competitors, St. Jude Medical, Inc. (NYSE:STJ), has done relatively well compared to Boston Scientific Corporation (NYSE:BSX). Its Angio-Seal device is the undisputed leader in its market, and it has not suffered from the extensive product recalls that plagued Boston Scientific Corporation (NYSE:BSX) and Medtronic.

In addition, St. Jude Medical, Inc. (NYSE:STJ) is investing heavily in atrial fibrillation and related devices that will directly compete with Medtronic’s offering. However, customer stickiness will enable Medtronic to remain the leader in the market, while St. Jude struggles to gain ground.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!